These talented and inspirational athletes each has a story worth sharing — and a powerful reason for their 26.2 mile journey.

Get to know the rare disease Neurofibromatosis, starting from the symptoms, causes, to the risk factors for this genetic ...

The Giorgio Foundation and the University of Pittsburgh announce the establishment of The Giorgio Foundation Endowed Chair in the School of Medicine's Department of Neurosurgery with a total ...

Neurological conditions are some of the most perplexing and confounding parts of medicine. The study of neurons and genes and ...

The law on assisted dying should be the same on both sides of the border - that’s the view of a young Chepstow man who has an ...

Colbeck Capital Management, a leading middle-market private credit firm focused on strategic lending, today announced its continued support of the Children’s Tumor Foundation ("CTF" or the "Foundation ...

A young boy from Cuba who was battling a medical condition died on Saturday after he and his family received a visa to travel to South Florida for treatment. Damir Ortiz was diagnosed with type 1 ...

In a significant step towards raising awareness and providing essential support for Neurofibromatosis Type 1 (NF1) patients, ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

Gomekli (mirdametinib) is the first treatment that is FDA approved for both adults and children with neurofibromatosis type 1 (NF1) who have plexiform neurofibromas (PN). Selumetinib, a drug that ...

Enriquez lives with chronic kidney disease, neurofibromatosis, which causes tumors to form, scoliosis and Raynaud's ...

Erratum: Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease We appreciate the shared commitment ...